Company news: Bod Science; Emyria by Martin Lane November 21, 2023November 22, 2023 Bod Science has yet to settle tranche one of its current capital raise following delays in […]
Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health by Martin Lane November 14, 2023November 14, 2023
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Company news: Setek Therapeutics; Emyria; Melodiol Global Health by Martin Lane October 9, 2023October 12, 2023
Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023October 3, 2023
Emyria completes acquisition of Pax Centre for A$1.7m by Martin Lane September 13, 2023September 13, 2023
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023September 4, 2023
Company news: Rua Bioscience; IDT Australia; Emyria; Elixinol Wellness; Neurotech; Hygrovest; Releaf Group/ICCM; Botanix by Martin Lane August 30, 2023August 31, 2023
Company news: Elixinol/The Sustainable Nutrition Group; Emyria by Steve Jones August 8, 2023August 10, 2023
Financial results: Bod Science; Zelira Therapeutics; Emyria; Epsilon Healthcare; Elixinol; MGC Pharma by Steve Jones August 1, 2023October 3, 2023
